Moreover, the lower frequencies of naïve CD4+ T cells and B cells in advanced NSCLC patients and COVID-19 patients compared with age-matched healthy volunteers is consistent with previous findings (Saavedra et al., 2017). Here, CD4 is linked to non-small cell lung carcinoma.